Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 6/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.41 |
| ▸ | DRD2 | P14416 | 4/20 | 0.40 |
| ▸ | DRD4 | P21917 | 4/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.40 |
| ▸ | CCR8 | P51685 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6166931 | 0.94 | CHRM3 (0.43) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6167790 | 0.92 | CHRM2 (0.43) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6165720 | 0.92 | CHRM3 (0.47) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6167614 | 0.92 | CHRM2 (0.44) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6170271 | 0.91 | CHRM2 (0.45) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6169683 | 0.90 | MEN1 (0.48) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6168017 | 0.88 | CHRM2 (0.44) | CHRM3CHRM2OPRM1CCR8CYP2D6 | |
| SCHEMBL6169679 | 0.88 | CHRM3 (0.48) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6168165 | 0.88 | CHRM3 (0.49) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6167793 | 0.86 | CCR8 (0.41) | CHRM3CHRM2DRD2DRD4OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1122253-B1 | QUINAZOLINONE DERIVATIVES | SUMITOMO PHARMA (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-6645971-B1 | Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2003-11-11 | — | — | US | disclosed |
| EP-1122253-A1 | QUINAZOLINONE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2001-08-08 | — | — | EP | disclosed |